Implications of drugs with rebate in Europe

Detalles Bibliográficos
Autores principales: Bonetti, Andrea, Giuliani, Jacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454721/
https://www.ncbi.nlm.nih.gov/pubmed/34557803
http://dx.doi.org/10.1016/j.lanepe.2021.100060
_version_ 1784570543456911360
author Bonetti, Andrea
Giuliani, Jacopo
author_facet Bonetti, Andrea
Giuliani, Jacopo
author_sort Bonetti, Andrea
collection PubMed
description
format Online
Article
Text
id pubmed-8454721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84547212021-09-22 Implications of drugs with rebate in Europe Bonetti, Andrea Giuliani, Jacopo Lancet Reg Health Eur Commentary Elsevier 2021-02-26 /pmc/articles/PMC8454721/ /pubmed/34557803 http://dx.doi.org/10.1016/j.lanepe.2021.100060 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Bonetti, Andrea
Giuliani, Jacopo
Implications of drugs with rebate in Europe
title Implications of drugs with rebate in Europe
title_full Implications of drugs with rebate in Europe
title_fullStr Implications of drugs with rebate in Europe
title_full_unstemmed Implications of drugs with rebate in Europe
title_short Implications of drugs with rebate in Europe
title_sort implications of drugs with rebate in europe
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454721/
https://www.ncbi.nlm.nih.gov/pubmed/34557803
http://dx.doi.org/10.1016/j.lanepe.2021.100060
work_keys_str_mv AT bonettiandrea implicationsofdrugswithrebateineurope
AT giulianijacopo implicationsofdrugswithrebateineurope

Ejemplares similares